Home health and hospice services provider Amedisys, Inc. (AMED) reported Tuesday an increase in third-quarter profit, helped by a nearly 21% growth in service revenues. The company also reaffirmed its outlook for fiscal 2009.
For the third quarter, net income attributable to Amedisys rose to $35.94 million or $1.29 per share from $23.49 million or $0.87 per share in the previous year.
On average, 16 analysts polled by Thomson Reuters expected the company to report earnings of $1.27 per share for the third quarter. Analysts' estimate typically exclude special items.
Operating income improved to $60.73 million from $43.64 million in the corresponding period of fiscal 2008.
Net service revenue for the quarter surged 20.7% to $388.26 million from $321.56 million, attributed to growth through base/start-up agencies. Fourteen analysts were expecting revenue of $384.44 million in the third quarter.
For the nine-month period, net income advanced to $98.04 million or $3.55 per share from $60.34 million or $2.25 per share in fiscal 2008. Service revenue grew 30.8% to $1.11 billion from $847.32 million.
Looking ahead, for the full year, the company maintained its earlier earnings guidance range of $4.75 - $4.90 per share. Amedisys also reiterated its revenue outlook of $1.475 billion - $1.500 billion, excluding the effects of any future acquisitions. Analysts are currently looking for earnings of $4.86 a share on revenue of $1.50 billion for the year.
AMED is currently trading at $41.21, down $1.90 or 4.41%, on the NASDAQ.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.